- Avricore, through its HealthTab(TM) flagship offering, is bringing health diagnosis and treatment closer to people
- The point-of-care testing market, which Avricore is part of, shows incredible potential for growth in the coming years
- Strategic investments and critical partnerships with other key players in the industry have allowed Avricore to stand out among its competitors
- This has also enabled the company to create value for stakeholders and better outcomes for patients
The point-of-care testing market is projected to be valued at $50.6 billion by 2025, up from $29.5 billion in 2020. This will represent a compounded annual growth rate (“CAGR”) of 11.4% during the forecast period, mainly fueled by the rising cases of infectious diseases, technological advancements of point-of-care devices, along with an increase in investments by key companies and players in the industry (https://ibn.fm/qn479).
One such player is Avricore Health (TSX.V: AVCR) (OTCQB: AVCRF), a company at the forefront of moving pharmacy forward. Described as a heath diagnostics technology innovator focused on acquiring and…
NOTE TO INVESTORS: The latest news and updates relating to AVCRF are available in the company’s newsroom at https://ibn.fm/AVCRF
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.
With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.
Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.
For more information, please visit https://www.InvestorWire.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer
InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@InvestorWire.com
InvestorWire is part of the InvestorBrandNetwork.
